Abstract:The mechanism of SENPs involved in human oxidative stress‐related diseases. Oxidative stress is employed to depict a series of responses detrimental to normal cellular functions resulting from an imbalance between intracellular oxidants, mainly reactive oxygen species and antioxidant defenses. Oxidative stress often contributes to the development of various diseases, including cancer, cardiovascular diseases, and neurodegenerative diseases. In this process, the relationship between small ubiquitin‐like modifier (SUMO) and oxidative stress has garnered significant attention, with its posttranslational modification (PTM) frequently serving as a marker of oxidative stress status. Sentrin/SUMO‐specific proteases (SENPs), affected by alternative splicing, PTMs such as phosphorylation and ubiquitination, and various protein interactions, are crucial molecules in the SUMO process. The human SENP family has six members (SENP1–3, SENP5–7), which are classified into two categories based on sequence similarity, substrate specificity, and subcellular location. They have two core functions in the human body: first, by cleaving the precursor SUMO and exposing the C‐terminal glycine, they initiate the SUMO process; second, they can specifically recognize and dissociate SUMO proteins bound to substrates, a process known as deSUMOylation. However, the connection between deSUMOylation and oxidative stress remains a relatively unexplored area despite their strong association with oxidative diseases such as cancer and cardiovascular disease. This article aims to illustrate the significant contribution of SENPs to the oxidative stress pathway through deSUMOylation by reviewing their structure and classification, their roles in oxidative stress, and the changes in their expression and activity in several typical oxidative stress‐related diseases.

Research progress of SENP inhibitors and SENP inhibitor bioassay methods

Development and Evaluation of a Highly Reliable Assay for SUMO-Specific Protease Inhibito R S

The Critical Roles of the SUMO-Specific Protease SENP3 in Human Diseases and Clinical Implications

Progress in the Discovery of Small Molecule Modulators of DeSUMOylation.

Structure-Based Specific Detection And Inhibition Of Monoamine Oxidases And Their Applications In Central Nervous System Diseases

Recent Research and Development of Inhibitors Targeting Sentrin-Specific Protease 1 for the Treatment of Cancers.

Identification of SENP1 Inhibitors Through in Silico Screening and Rational Drug Design.

Benzothiophene-2-carboxamide derivatives as SENPs inhibitors with selectivity within SENPs family

Emerging role of SENP1 in tumorigenesis and cancer therapy

SUMO proteases: from cellular functions to disease

SUMO‐specific proteases: SENPs in oxidative stress‐related signaling and diseases

Design, synthesis, and biological evaluation of benzodiazepine-based SUMO-specific protease 1 inhibitors.

Assessment of SENP3-interacting proteins in hepatocytes treated with diethylnitrosamine by BioID assay

2-(4-Chlorophenyl)-2-oxoethyl 4-Benzamidobenzoate Derivatives, a Novel Class of SENP1 Inhibitors: Virtual Screening, Synthesis and Biological Evaluation.

Protein SUMOylation Modification and Its Associations with Disease

Discovery and radiosensitization research of ursolic acid derivatives as SENP1 inhibitors

Role of Pericyte‐derived SENP1 in Neuronal Injury after Brain Ischemia

Highly Sensitive Nanochannel Device for the Detection of SUMO1 Peptides

Highly Sensitive Assays for SUMOylation and Small Ubiquitin-Like Modifier-Dependent Protein–protein Interactions

Small-Molecule Inhibitors Targeting Protein SUMOylation As Novel Anticancer Compounds.

Small Ubiquitin-Like Modifier Protein-Specific Protease 1 and Prostate Cancer